Consult your healthcare professional prior to use
Missaglia, S., Coleman, R., Mordente, A
In some embodiments, a formulation described herein, further comprises a gelling agent (e.g., poloxamer 407) and provides release of the therapeutic agent over a period of from about 2 days to about 7 days
Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Sugar Land, Katy, & The Woodlands: Premium wellness access for the outer loops and surrounding communities
Service providers reported working with each victim to set achievable goals as part of his or her service plan